LAMBDAVISION INCORPORATED
SBIR Phase III award from National Aeronautics and Space Administration.
Summary
LambdaVision received almost $2 million from NASA for a Phase III SBIR project to manufacture protein-based artificial retinas in space. The work focuses on developing this medical technology through in-space production methods.
- Amount
- $1,975,000
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- SBIR · Phase III
- NAICS
- 541713 · RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
- Place of performance
- CT
- Period
- 2025-06-24 → 2028-03-23
Technology domains
Space & Satellite Human Performance & Medical Materials & Manufacturing
Description
FY25 SBIR PHASE III - IN SPACE PRODUCTION OF PROTEIN- BASED ARTIFICIAL RETINAS